9,10-alpha,alpha-OH-taxane analogs and methods for production thereof

Details for Australian Patent Application No. 2004275881 (hide)

Owner Tapestry Pharmaceuticals, Inc.

Inventors Ferrara, James; Zygmut, Jan; McChesney, James D.

Agent Griffith Hack

Pub. Number AU-A-2004275881

PCT Pub. Number WO2005/030150

Priority 60/506,680 25.09.03 US

Filing date 27 September 2004

Wipo publication date 7 April 2005

International Classifications

C07D 405/02 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030150 Priority application(s): WO2005/030150

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275885-Hippophae rhamnoides compositions for cancer therapy

2004275878-Inherently radiopaque polymeric products for embolotherapy